| Current and future treatments for Alzheimer's disease. | |
| | |
MedLine Citation:
|
PMID: 23277790 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Alzheimer's dementia (AD) is increasingly being recognized as one of the most important medical and social problems in older people in industrialized and non-industrialized nations. To date, only symptomatic treatments exist for this disease, all trying to counterbalance the neurotransmitter disturbance. Three cholinesterase inhibitors (CIs) are currently available and have been approved for the treatment of mild to moderate AD. A further therapeutic option available for moderate to severe AD is memantine, an N-methyl-D-aspartate receptor noncompetitive antagonist. Treatments capable of stopping or at least effectively modifying the course of AD, referred to as 'disease-modifying' drugs, are still under extensive research. To block the progression of the disease they have to interfere with the pathogenic steps responsible for the clinical symptoms, including the deposition of extracellular amyloid β plaques and intracellular neurofibrillary tangle formation, inflammation, oxidative damage, iron deregulation and cholesterol metabolism. In this review we discuss current symptomatic treatments and new potential disease-modifying therapies for AD that are currently being studied in phase I-III trials. |
| | |
Authors:
|
Konstantina G Yiannopoulou; Sokratis G Papageorgiou |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Therapeutic advances in neurological disorders Volume: 6 ISSN: 1756-2856 ISO Abbreviation: Ther Adv Neurol Disord Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-01-01 Completed Date: 2013-01-02 Revised Date: 2013-04-18 |
Medline Journal Info:
|
Nlm Unique ID: 101480242 Medline TA: Ther Adv Neurol Disord Country: England |
Other Details:
|
Languages: eng Pagination: 19-33 Citation Subset: - |
Affiliation:
|
Neurological Department, Laiko General Hospital of Athens, 15127Ag. Thoma 17, Athens, Greece. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical testing for neutralizing antibodies to interferon-? in multiple sclerosis.
Next Document: Ventricular tachycardia during basilar-type migraine attack.